Ignite Creation Date:
2024-05-05 @ 4:41 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00290771
Status:
TERMINATED
Last Update Posted:
2011-05-16
First Post:
2006-02-10
Brief Title:
Efficacy and Safety of Imatinib Mesylate Plus Hydroxyurea HU in Patients With Recurrent Glioblastoma Multiforme GBM
Sponsor:
Novartis
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-02
Start Date Type:
None
Primary Completion Date:
2008-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-08
Completion Date Type:
ACTUAL
First Submit Date:
2006-02-10
First Submit QC Date:
February 10 2006
Study First Post Date:
2006-02-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2011-05-16
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-04-20
Last Update Post Date:
2011-05-16
Last Update Post Date Type:
ESTIMATED